1. Home
  2. NOTV vs GSIW Comparison

NOTV vs GSIW Comparison

Compare NOTV & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • GSIW
  • Stock Information
  • Founded
  • NOTV 1974
  • GSIW 2016
  • Country
  • NOTV United States
  • GSIW Hong Kong
  • Employees
  • NOTV N/A
  • GSIW 17
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • GSIW
  • Sector
  • NOTV Health Care
  • GSIW
  • Exchange
  • NOTV Nasdaq
  • GSIW Nasdaq
  • Market Cap
  • NOTV 28.7M
  • GSIW 33.9M
  • IPO Year
  • NOTV 1997
  • GSIW 2023
  • Fundamental
  • Price
  • NOTV $0.87
  • GSIW $0.15
  • Analyst Decision
  • NOTV Strong Buy
  • GSIW
  • Analyst Count
  • NOTV 1
  • GSIW 0
  • Target Price
  • NOTV $5.00
  • GSIW N/A
  • AVG Volume (30 Days)
  • NOTV 1.6M
  • GSIW 1.5M
  • Earning Date
  • NOTV 12-03-2025
  • GSIW 01-01-0001
  • Dividend Yield
  • NOTV N/A
  • GSIW N/A
  • EPS Growth
  • NOTV N/A
  • GSIW N/A
  • EPS
  • NOTV N/A
  • GSIW N/A
  • Revenue
  • NOTV $505,299,000.00
  • GSIW $5,368,221.00
  • Revenue This Year
  • NOTV $5.64
  • GSIW N/A
  • Revenue Next Year
  • NOTV $5.16
  • GSIW N/A
  • P/E Ratio
  • NOTV N/A
  • GSIW N/A
  • Revenue Growth
  • NOTV 0.85
  • GSIW 283.23
  • 52 Week Low
  • NOTV $0.66
  • GSIW $0.09
  • 52 Week High
  • NOTV $6.48
  • GSIW $1.79
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 36.75
  • GSIW 49.95
  • Support Level
  • NOTV $0.77
  • GSIW $0.14
  • Resistance Level
  • NOTV $0.86
  • GSIW $0.15
  • Average True Range (ATR)
  • NOTV 0.13
  • GSIW 0.01
  • MACD
  • NOTV -0.01
  • GSIW -0.00
  • Stochastic Oscillator
  • NOTV 35.07
  • GSIW 53.80

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

Share on Social Networks: